Abstract
The objective of this study was to investigate the therapeutic effect of a tumor necrosis factor-alpha (TNF-α) antagonist on the sexual quality of life of male patients with ankylosing spondylitis (AS). In this open-label study, 42 AS patients were grouped into the TNF-α antagonist treatment group and the non-TNF-α antagonist treatment group for 3 months. Clinical and laboratory indices and changes in the sexual quality of life were compared to assess the efficacy of TNF-α antagonists on sexual activity. The relationship between sexual quality and disease activity was analyzed. There were no significant differences in baseline data between the two groups. After treatment, disease activity and quality of life were improved in these two groups. The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score (1.9 ± 1.6 vs. 3.0 ± 1.3, p = 0.020), erythrocyte sedimentation rate (ESR) (9 ± 7 mm/1 h vs. 18 ± 17 mm/1 h, p = 0.031), and C-reactive protein (CRP) levels (1.8 ± 2.1 mg/dl vs. 6.2 ± 8.5 mg/dl, p = 0.035) were significantly lower in the TNF-α antagonist treatment group than in the non-TNF-α antagonist treatment group. The extent of improvement in the quality of life was more evident in the TNF-α antagonist treatment group. The average degree of improvement in the quality of life was negatively related to the BASDAI score and the Bath Ankylosing Spondylitis Functional Index score in the TNF-α antagonist treatment group (r = −0.497, p = 0.018; r = −0.558, p = 0.007, respectively). Sexual quality of life and disease activity are improved after treatment with TNF-α antagonists in male patients with AS. The extent of improvement in sexual quality and disease activity are positively related.
Similar content being viewed by others
References
World Association for Sexual Health (2005) Working definitions after WHO technical consultation on sexual health. http://www.worldsexualhealth. Org/who def. asp
Ozkorumak E, Karkucak M, Civil F et al (2011) Sexual function in male patients with ankylosing spondylitis. Int J Impot Res 23(6):262–267
Hill J (2004) The impact of rheumatoid arthritis on patients’ sex lives. Nurs Times 100:34–35
Oh JS, Heo HM, Kim YG et al (2009) The effect of anti-tumor necrosis factor agents on sexual dysfunction in male patients with ankylosing spondylitis: a pilot study. Int J Impot Res 21:372–375
Rostom S, Mengat M, Mawani N et al (2013) Sexual activity in Moroccan men with ankylosing spondylitis. Rheumatol Int 33(6):1469–1474
Pirildar T, Muezzinoglu T, Pirildar S (2004) Sexual function in ankylosing spondylitis: a study of 65 men. J Urol 171:1598–1600
Shen B, Zhang A, Liu J et al (2013) A primary analysis of sexual problems in Chinese patients with ankylosing spondylitis. Rheumatol Int 33(6):1429–1435
Bal S, Bal K, Turan Y et al (2011) Sexual functions in ankylosing spondylitis. Rheumatol Int 31(7):889–894
Cakar E, Dincer U, Kiralp MZ et al (2007) Sexual problems in male ankylosing spondylitis patients: relationship with functionality, disease activity, quality of life, and emotional status. Clin Rheumatol 26:1607–1613
Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnosis criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368
DAI JC (2005) The description of the modified sexual life quality questionnaire. J Androl 19:71–72
Fisher WA, Rosen RC, Mollen M et al (2005) Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med 2:699–708
Ostensen M (2004) New insights into sexual functioning and fertility in rheumatic diseases. Best Pract Res Clin Rheumatol 18(2):219–232
Araujo DB, Borba EF, Abdo CHN et al (2010) Função sexual em doenças reumáticas. Acta Reumatol Port 35(1):16–23
Dincer U, Cakar E, Kiralp MZ et al (2007) Assessment of sexual dysfunction in male patients with ankylosing spondylitis. Rheumatol Int 27:561–566
Healey EL, Haywood KL, Jordan KP et al (2009) Ankylosing spondylitis and its impact on sexual relationships. Rheumatology 48:1378–1381
Helland Y, Kjeken I, Steen E et al (2011) Rheumatic disease and sexuality: disease impact and self management strategies. Arthritis Care Res 63(5):743–750
Tristano AG (2009) The impact of rheumatic disease on sexual function. Rheumatol Int 29(8):853–860
Woodward JM, Hass SL, Woodward PJ (2002) Reliability and validity of the sexual life quality questionnaire (SLQQ). Qual Life Res 11:365–377
Callhoff J, Sieper J, Weiß A et al (2014) Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis. Ann Rheum Dis 5:20–32
Prince DS, McGuigan LE, McGirr EE (2014) Working life and physical activity in ankylosing spondylitis pre and post anti-tumor necrosis factor-alpha therapy. Int J Rheum Dis 17(2):165–172
Heikkila S, Ronni S, Kautiainen HJ et al (2002) Functional impairment in spondyloarthropathy and fibromyalgia. J Rheumatol 29(7):1415–1418
Gallinaro AL, Akagawa LL, Otuzi MH et al (2012) Sexual activity in ankylosing spondylitis. Rev Bras Reumatol 52(6):887–891
Karadag F, Ozcan H, Karul AB et al (2007) Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients. Respirology (Carlton, Vic) 12:248–253
Hotston MR, Jeremy JY, Bloor J et al (2007) Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide. BJU Int 99:612–618
Ethics and informed consent statement
The study was approved by the Ethics Committee. All patients provided written informed consent prior to study participation.
Disclosures
None of the authors has any disclosures to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dong, X., Zheng, Y., Shi, TY. et al. Effects of tumor necrosis factor-alpha on sexual activity of male patients with ankylosing spondylitis. Clin Rheumatol 34, 915–920 (2015). https://doi.org/10.1007/s10067-014-2751-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2751-7